These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 32052554
41. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, Behr J, Capellier G, Soumagne T, Pili-Floury S, Besch G, Mourey G, Lepiller Q, Chirouze C, Schiele F, Chopard R, Meneveau N. Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32907890 [Abstract] [Full Text] [Related]
42. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G, PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics). Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816 [Abstract] [Full Text] [Related]
43. A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need? Michiels JJ, Gadisseur A, Van Der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, Trienekens PH, Hoogsteden H, Pattynama PM. Int Angiol; 2005 Mar; 24(1):27-39. PubMed ID: 15876996 [Abstract] [Full Text] [Related]
44. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study). Ageno W, Cosmi B, Ghirarduzzi A, Santoro R, Bucherini E, Poli D, Prisco D, Alatri A, Pengo V, Galli L, Dentali F, Palareti G. Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507 [Abstract] [Full Text] [Related]
45. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Kucher N, Schroeder V, Kohler HP. Thromb Haemost; 2003 Sep; 90(3):434-8. PubMed ID: 12958612 [Abstract] [Full Text] [Related]
46. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial. Raj L, Presles E, Le Mao R, Robin P, Sanchez O, Pernod G, Bertoletti L, Jego P, Lemarié CA, Leven F, Hoffmann C, Planquette B, Le Roux PY, Slaun PY, Nonent M, Girard P, Lacut K, Mélac S, Guégan M, Mismetti P, Laporte S, Meyer G, Leroyer C, Tromeur C, Couturaud F, PADIS-PE InvestigatorsDépartement de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, and EA 3878, CIC INSERM 1412, Brest, France.. Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853 [Abstract] [Full Text] [Related]
47. D-Dimer and thrombus burden in acute pulmonary embolism. Keller K, Beule J, Balzer JO, Dippold W. Am J Emerg Med; 2018 Sep; 36(9):1613-1618. PubMed ID: 29371044 [Abstract] [Full Text] [Related]
48. Prognostic factors of clot resolution on follow-up computed tomography angiography and recurrence after a first acute pulmonary embolism. Aranda C, Gonzalez P, Gagliardi L, Peralta L, Jimenez A. Clin Respir J; 2021 Sep; 15(9):949-955. PubMed ID: 33960121 [Abstract] [Full Text] [Related]
49. Duration of anticoagulation after isolated pulmonary embolism. Palareti G, Cosmi B, Antonucci E, Legnani C, Erba N, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P, DULCIS investigators. Eur Respir J; 2016 May; 47(5):1429-35. PubMed ID: 26917615 [Abstract] [Full Text] [Related]
50. Are clinical parameters and biomarkers predictive of severity of acute pulmonary emboli on CTPA? Jeebun V, Doe SJ, Singh L, Worthy SA, Forrest IA. QJM; 2010 Feb; 103(2):91-7. PubMed ID: 20040533 [Abstract] [Full Text] [Related]
51. Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism. A comparison with pulmonary angiography. Sijens PE, van Ingen HE, van Beek EJ, Berghout A, Oudkerk M. Thromb Haemost; 2000 Aug; 84(2):156-9. PubMed ID: 10959684 [Abstract] [Full Text] [Related]
52. Imaging tests in the diagnosis of pulmonary embolism. Mos IC, Klok FA, Kroft LJ, de Roos A, Huisman MV. Semin Respir Crit Care Med; 2012 Apr; 33(2):138-43. PubMed ID: 22648485 [Abstract] [Full Text] [Related]
53. Use of D-dimer and lower extremity Doppler ultrasound results to obviate the need for computerised tomographic pulmonary angiography. Mukhopadhyay A, Venkatesh S, Goh PS, Lim TK. Ann Acad Med Singap; 2006 Dec; 35(12):858-63. PubMed ID: 17218996 [Abstract] [Full Text] [Related]
54. Investigation of the need for computed tomography pulmonary angiography in the decision to discontinue treatment for pulmonary thromboembolism. Çelik E, Araz Ö, Kerget B, Tezcan A, Uçar EY, Akgün M, Sağlam L. Heart Lung; 2022 Dec; 56():105-111. PubMed ID: 35830781 [Abstract] [Full Text] [Related]
55. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, Kramer MH, Kruip MJ, Kwakkel-van Erp JM, Leebeek FW, Nijkeuter M, Prins MH, Sohne M, Tick LW, Christopher Study Investigators. JAMA; 2006 Jan 11; 295(2):172-9. PubMed ID: 16403929 [Abstract] [Full Text] [Related]
56. Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools. Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, Trienekens PH, Hoogsteden H, Pattynama PM. Semin Vasc Med; 2005 Nov 11; 5(4):351-64. PubMed ID: 16302156 [Abstract] [Full Text] [Related]
57. Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Panju A, van Beek EJ, Patel A. Thromb Haemost; 1995 Jan 11; 73(1):35-8. PubMed ID: 7740493 [Abstract] [Full Text] [Related]
58. Factors Associated with Pulmonary Embolism Recurrence and the Benefits of Long-term Anticoagulant Therapy. Anniccherico-Sanchez FJ, Alonso-Martinez JL, Urbieta-Echezarreta MA, Villar-Garcia I, Rojo-Alvaro J. Cardiovasc Hematol Disord Drug Targets; 2017 Jan 11; 17(3):205-211. PubMed ID: 28925904 [Abstract] [Full Text] [Related]
59. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19. Choi JJ, Wehmeyer GT, Li HA, Alshak MN, Nahid M, Rajan M, Liu B, Schatoff EM, Elahjji R, Abdelghany Y, D'Angelo D, Crossman D, Evans AT, Steel P, Pinheiro LC, Goyal P, Safford MM, Mints G, DeSancho MT. Thromb Res; 2020 Dec 11; 196():318-321. PubMed ID: 32977130 [No Abstract] [Full Text] [Related]
60. [Negative D-dimers and exclusion of venous thromboembolism--own experience]. Dworakowska D, Kazimierska E, Weyer-Hepka J, Skibowska-Bielińska A, Swiatkowska-Stodulska R, Lubińska M, Czestochowska E. Pol Arch Med Wewn; 2005 Dec 11; 114(6):1200-3. PubMed ID: 16789489 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]